Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: Study of risk factors

Journal of Heart and Lung Transplantation

Volumn 20, Issue 12, 2001, Pages 1274-1281

  Monforte, Víctor ^a   Roman, Antonio ^a   Gavalda, Joan ^a   Bravo, Carles ^a   Tenorio, Luis ^a   Ferrer, Adelaida ^a   Maestre, José ^a   Morell, Ferran ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FUNGIZONA;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; ASPERGILLOSIS; BRONCHOSPASM; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEBULIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR;

ADOLESCENT; ADULT; AEROSOLS; AGED; AMPHOTERICIN B; ASPERGILLOSIS; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; OPPORTUNISTIC INFECTIONS; RISK FACTORS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 0035667914     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00364-3     Document Type: Article

References (38)

1. Aspergillus and lung transplantation
2. Aspergillus infection in single and double lung transplant recipients
3. Aspergillus airway colonization and invasive disease after lung transplantation
4. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis
5. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis
6. Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis
7. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients
8. A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia
9. Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients
10. Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients
11. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial
12. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
13. Antifungal prophylaxis during the early postoperative period of lung transplantation
14. Invasive aspergillosis
15. Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
16. Aïllaments de fongs a partir de la pols domiciliària en asmàtics i persones sanes
17. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit
18. Fungal and bacterial infections in the immunocompromised host
19. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
20. Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation: A case report
21. Lung transplantation
22. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients
23. Cytomegalovirus viremia and bacteremia in renal allograft recipients
24. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection
25. Primary cytomegalovirus and opportunistic infections: Incidence in renal transplant recipients
26. Infectious disease complications of renal transplantation
27. Assessment of the status of cell-mediated immunity in cytomegalovirus-infected renal allograft recipients
28. Cellullar immune response to cytomegalovirus infection after renal transplantation
29. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients
30. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients
31. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
32. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies
33. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease
34. Systemic availability of itraconazole in lung transplantation
35. The physiologic effects of inhaled amphotericin B
36. The toxicity of daily inhaled amphotericin B
37. Deposition of amphotericin B aerosols in pulmonary aspergilloma
38. Pharmacokinetics and distribution of nebulized amphotericin B (nAmp) in lung transplantation